Massive arthritis drug safety study completed in denmark
NCT ID NCT05421442
First seen Jan 08, 2026 · Last updated May 10, 2026 · Updated 17 times
Summary
This study looked at the safety of the drug abatacept in over 38,000 people with rheumatoid arthritis or psoriatic arthritis in Denmark. Researchers used a national health database to track rates of different cancers. The goal was to gather more information on the drug's long-term safety in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Lawrenceville, New Jersey, 08543, United States
Conditions
Explore the condition pages connected to this study.